{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:31:25Z","timestamp":1768833085402,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.06.102","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T22:14:12Z","timestamp":1530051252000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The inhibition of Hippo\/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation"],"prefix":"10.1016","volume":"106","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiufang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.102_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11938-018-0182-2","article-title":"Intensive care management of patients with cirrhosis","volume":"16","author":"Olson","year":"2018","journal-title":"Curr. Treat Options Gastroenterol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2017.0078","article-title":"Histopathological evaluation of liver fibrosis and cirrhosis regression","volume":"23","author":"Lo","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10286020.2016.1276168","article-title":"Recent progression in the utilization of autophagy-regulating nature compound as anti-liver fibrosis agents","volume":"19","author":"Ge","year":"2017","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2018.06.102_bib0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.biopha.2017.10.158","article-title":"The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice","volume":"97","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.06.102_bib0030","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.3892\/mmr.2017.6993","article-title":"Magnesium isoglycyrrhizinate protects against renalischemiareperfusion injury in a rat model via antiinflammation, antioxidation and antiapoptosis","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.06.102_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3526903","article-title":"Amelioration of ethanol-induced hepatitis by magnesium isoglycyrrhizinate through inhibition of neutrophil cell infiltration and oxidative damage","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2018.06.102_bib0040","first-page":"1","article-title":"Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis","volume":"18","author":"Vasseur","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0045","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1038\/s41598-017-08689-1","article-title":"NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with schistosoma japonicum in a Syk-dependent manner","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.06.102_bib0050","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.7150\/ijbs.15154","article-title":"Deficiency of DJ-1 ameliorates liver fibrosis through inhibition of hepatic ROS production and inflammation","volume":"12","author":"Yu","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2018.06.102_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.06.102_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-016-0005-6","article-title":"Roles of hepatic stellate cells in liver inflammation: a new perspective","volume":"36","author":"Fujita","year":"2016","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.biopha.2018.06.102_bib0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/biof.1390","article-title":"Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo","volume":"43","author":"Bian","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2018.06.102_bib0070","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jhep.2015.07.008","article-title":"Emerging evidence on the role of the Hippo\/YAP pathway in liver physiology and cancer","volume":"63","author":"Yimlamai","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0075","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.4103\/0366-6999.218013","article-title":"Advanced role of Hippo signaling in endometrial fibrosis: implications for intrauterine adhesion","volume":"130","author":"Zhu","year":"2017","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.biopha.2018.06.102_bib0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","author":"Lu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.06.102_bib0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","article-title":"Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis","volume":"152","author":"Patel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2018.06.102_bib0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.freeradbiomed.2016.10.498","article-title":"ROS-JNK1\/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis","volume":"101","author":"Zhang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2018.06.102_bib0095","doi-asserted-by":"crossref","first-page":"e2886","DOI":"10.1038\/cddis.2017.255","article-title":"Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2018.06.102_bib0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.redox.2016.12.021","article-title":"Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell","volume":"11","author":"Zhang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/MEG.0b013e3283652c46","article-title":"Serum albumin and prothrombin time before entecavir treatment in chronic hepatitis B or cirrhosis are related to amelioration of liver function after treatment","volume":"25","author":"Saito","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2018.06.102_bib0115","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signaling and liver disease","volume":"283","author":"I","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2018.06.102_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2018.06.102_bib0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","article-title":"Matrix metalloproteinases (MMPs) in liver diseases","volume":"7","author":"Naim","year":"2017","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0130","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0135","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1111\/jcmm.13281","article-title":"WWC2 is an independent prognostic factor and prevents invasion via Hippo signaling in hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2018.06.102_bib0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.06.102_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2018.06.102_bib0150","first-page":"4755","article-title":"Magnesium isoglycyrrhizinate protects hepatic LO2 cells from ischemia\/reperfusion induced injury","volume":"7","author":"Huang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2017.05.032","article-title":"Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-kappaB\/NLRP3 inflammasome activation and lipid metabolism disorder","volume":"809","author":"Zhao","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0160","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.3748\/wjg.v21.i43.12370","article-title":"Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function","volume":"21","author":"Tang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/iub.1639","article-title":"Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol induced hepatocyte steatosis and apoptosis","volume":"69","author":"Lu","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2018.06.102_bib0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2013.09.042","article-title":"Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro","volume":"721","author":"Zhang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0175","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3892\/etm.2017.5001","article-title":"Ursolic acid suppresses TGF-beta1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling","volume":"14","author":"Yu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2018.06.102_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.22017","article-title":"Nootkatone confers hepatoprotective and anti-fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis","volume":"32","author":"Kurdi","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2018.06.102_bib0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/iub.1348","article-title":"Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway","volume":"67","author":"Wu","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2018.06.102_bib0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.dld.2012.02.015","article-title":"Imidazolium salt attenuates thioacetamide-induced liver fibrosis in mice by modulating inflammation and oxidative stress","volume":"44","author":"Mohamed Suhaimi","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2018.06.102_bib0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biochi.2017.05.017","article-title":"Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo\/Yap and TGF-\u03b21\/Smad signaling","volume":"140","author":"Perumal","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2018.06.102_bib0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejps.2016.10.002","article-title":"Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine","volume":"96","author":"Jin","year":"2017","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218331871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218331871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:34:16Z","timestamp":1750880056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218331871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"alternative-id":["S0753332218331871"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.102","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibition of Hippo\/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}